These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 12751984)

  • 1. Effects of reducing contingency management values on heroin and cocaine use for buprenorphine- and desipramine-treated patients.
    Kosten T; Poling J; Oliveto A
    Addiction; 2003 May; 98(5):665-71. PubMed ID: 12751984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Desipramine and contingency management for cocaine and opiate dependence in buprenorphine maintained patients.
    Kosten T; Oliveto A; Feingold A; Poling J; Sevarino K; McCance-Katz E; Stine S; Gonzalez G; Gonsai K
    Drug Alcohol Depend; 2003 Jun; 70(3):315-25. PubMed ID: 12757969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comorbid major depressive disorder as a prognostic factor in cocaine-abusing buprenorphine-maintained patients treated with desipramine and contingency management.
    Gonzalez G; Feingold A; Oliveto A; Gonsai K; Kosten TR
    Am J Drug Alcohol Abuse; 2003 Aug; 29(3):497-514. PubMed ID: 14510037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of treatment outcome by baseline urine cocaine results and self-reported cocaine use for cocaine and opioid dependence.
    Sofuoglu M; Gonzalez G; Poling J; Kosten TR
    Am J Drug Alcohol Abuse; 2003; 29(4):713-27. PubMed ID: 14713135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Desipramine in opioid-dependent cocaine abusers maintained on buprenorphine vs methadone.
    Oliveto AH; Feingold A; Schottenfeld R; Jatlow P; Kosten TR
    Arch Gen Psychiatry; 1999 Sep; 56(9):812-20. PubMed ID: 12884887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methadone versus buprenorphine with contingency management or performance feedback for cocaine and opioid dependence.
    Schottenfeld RS; Chawarski MC; Pakes JR; Pantalon MV; Carroll KM; Kosten TR
    Am J Psychiatry; 2005 Feb; 162(2):340-9. PubMed ID: 15677600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Depression predicts higher rates of heroin use on desipramine with buprenorphine than with methadone.
    Kosten T; Falcioni J; Oliveto A; Feingold A
    Am J Addict; 2004; 13(2):191-201. PubMed ID: 15204669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utility of crossover designs in clinical trials: efficacy of desipramine vs. placebo in opioid-dependent cocaine abusers.
    Feingold A; Oliveto A; Schottenfeld R; Kosten TR
    Am J Addict; 2002; 11(2):111-23. PubMed ID: 12028741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Desipramine treatment for cocaine dependence in buprenorphine- or methadone-treated patients: baseline urine results as predictor of response.
    Kosten T; Sofuoglu M; Poling J; Gonsai K; Oliveto A
    Am J Addict; 2005; 14(1):8-17. PubMed ID: 15804873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of dose and contingency management procedures in LAAM-maintained cocaine-dependent patients.
    Oliveto A; Poling J; Sevarino KA; Gonsai KR; McCance-Katz EF; Stine SM; Kosten TR
    Drug Alcohol Depend; 2005 Aug; 79(2):157-65. PubMed ID: 16002025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Buprenorphine medication versus voucher contingencies in promoting abstinence from opioids and cocaine.
    Chopra MP; Landes RD; Gatchalian KM; Jackson LC; Buchhalter AR; Stitzer ML; Marsch LA; Bickel WK
    Exp Clin Psychopharmacol; 2009 Aug; 17(4):226-36. PubMed ID: 19653788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Desipramine, amantadine, or fluoxetine in buprenorphine-maintained cocaine users.
    Oliveto A; Kosten TR; Schottenfeld R; Falcioni J; Ziedonis D
    J Subst Abuse Treat; 1995; 12(6):423-8. PubMed ID: 8749726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of opiate maintenance therapy and adjunctive interventions for opioid dependence with comorbid cocaine use disorders: A systematic review and meta-analysis of controlled clinical trials.
    Castells X; Kosten TR; CapellĂ  D; Vidal X; Colom J; Casas M
    Am J Drug Alcohol Abuse; 2009; 35(5):339-49. PubMed ID: 20180662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Six-month trial of bupropion with contingency management for cocaine dependence in a methadone-maintained population.
    Poling J; Oliveto A; Petry N; Sofuoglu M; Gonsai K; Gonzalez G; Martell B; Kosten TR
    Arch Gen Psychiatry; 2006 Feb; 63(2):219-28. PubMed ID: 16461866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Desipramine treatment of cocaine-dependent patients with depression: a placebo-controlled trial.
    McDowell D; Nunes EV; Seracini AM; Rothenberg J; Vosburg SK; Ma GJ; Petkova E
    Drug Alcohol Depend; 2005 Nov; 80(2):209-21. PubMed ID: 15913920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison between low-magnitude voucher and buprenorphine medication contingencies in promoting abstinence from opioids and cocaine.
    Gross A; Marsch LA; Badger GJ; Bickel WK
    Exp Clin Psychopharmacol; 2006 May; 14(2):148-56. PubMed ID: 16756418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Shaping cocaine abstinence by successive approximation.
    Preston KL; Umbricht A; Wong CJ; Epstein DH
    J Consult Clin Psychol; 2001 Aug; 69(4):643-54. PubMed ID: 11550730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of desipramine or carbamazepine to placebo for crack cocaine-dependent patients.
    Campbell J; Nickel EJ; Penick EC; Wallace D; Gabrielli WF; Rowe C; Liskow B; Powell BJ; Thomas HM
    Am J Addict; 2003; 12(2):122-36. PubMed ID: 12746087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Buprenorphine versus methadone in the treatment of opioid dependence: self-reports, urinalysis, and addiction severity index.
    Strain EC; Stitzer ML; Liebson IA; Bigelow GE
    J Clin Psychopharmacol; 1996 Feb; 16(1):58-67. PubMed ID: 8834420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluoxetine treatment of depressive disorders in methadone-maintained opioid addicts.
    Petrakis I; Carroll KM; Nich C; Gordon L; Kosten T; Rounsaville B
    Drug Alcohol Depend; 1998 May; 50(3):221-6. PubMed ID: 9649975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.